141 related articles for article (PubMed ID: 32619546)
1. Systemic Corticosteroid Use after Central Serous Chorioretinopathy Diagnosis.
Azad AD; Zhou M; Afshar AR; Bakri SJ; Pershing S
Ophthalmology; 2021 Jan; 128(1):121-129. PubMed ID: 32619546
[TBL] [Abstract][Full Text] [Related]
2. Association of Corticosteroid Use With Incidence of Central Serous Chorioretinopathy in South Korea.
Rim TH; Kim HS; Kwak J; Lee JS; Kim DW; Kim SS
JAMA Ophthalmol; 2018 Oct; 136(10):1164-1169. PubMed ID: 30098167
[TBL] [Abstract][Full Text] [Related]
3. Central Serous Chorioretinopathy in a 14-year-old atopic boy: a case report.
Ranno S; Fontanel L; Ruggiero E; Nucci P; Radice P; Donati S
Ital J Pediatr; 2023 Jan; 49(1):1. PubMed ID: 36597009
[TBL] [Abstract][Full Text] [Related]
4. CHOROIDAL THICKNESS OF CENTRAL SEROUS CHORIORETINOPATHY SECONDARY TO CORTICOSTEROID USE.
Honda S; Miki A; Kusuhara S; Imai H; Nakamura M
Retina; 2017 Aug; 37(8):1562-1567. PubMed ID: 27787451
[TBL] [Abstract][Full Text] [Related]
5. Increased risk of glaucoma development in patients with central serous chorioretinopathy: results of a 11-year population-based cohort study.
Huang YT; Wan L; Cheng YD; Yu TS; Hung YT; Rujikajorn K; Chen JJ; Wu MY; Tsai FJ; Lin HJ; Tien PT
Graefes Arch Clin Exp Ophthalmol; 2023 Dec; 261(12):3457-3464. PubMed ID: 37581651
[TBL] [Abstract][Full Text] [Related]
6. A case report of systemic lupus erythematosus combined with central serous chorioretinopathy treated with glucocorticoids.
Rao Q; Ku M; Wan Q
J Int Med Res; 2023 Mar; 51(3):3000605231163716. PubMed ID: 36999279
[TBL] [Abstract][Full Text] [Related]
7. Corticosteroids usage and central serous chorioretinopathy: a meta-analysis.
Ge G; Zhang Y; Zhang Y; Xu Z; Zhang M
Graefes Arch Clin Exp Ophthalmol; 2020 Jan; 258(1):71-77. PubMed ID: 31734720
[TBL] [Abstract][Full Text] [Related]
8. Half-time photodynamic therapy in treatment of chronic central serous chorioretinopathy.
Sheptulin V; Purtskhvanidze K; Roider J
Graefes Arch Clin Exp Ophthalmol; 2018 Nov; 256(11):2027-2034. PubMed ID: 30097783
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Adalimumab for Chronic Vogt-Koyanagi-Harada Disease Refractory to Conventional Corticosteroids and Immunosuppressive Therapy and Complicated by Central Serous Chorioretinopathy.
Takayama K; Obata H; Takeuchi M
Ocul Immunol Inflamm; 2020 Apr; 28(3):509-512. PubMed ID: 31268769
[No Abstract] [Full Text] [Related]
10. Isolated pigment epithelium detachment: evidence for relation to central serous chorioretinopathy and effect of photodynamic therapy.
Arif F; Pryds A; Larsen M
Acta Ophthalmol; 2018 Dec; 96(8):821-827. PubMed ID: 30246489
[TBL] [Abstract][Full Text] [Related]
11. Receipt of Eye Care Services among Medicare Beneficiaries with and without Dementia.
Pershing S; Goldstein MK; Henderson VW; Bundorf MK; Lu Y; Rahman M; Stein JD
Ophthalmology; 2020 Aug; 127(8):1000-1011. PubMed ID: 32317179
[TBL] [Abstract][Full Text] [Related]
12. Half-Fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy: Predisposing Factors for Visual Acuity Outcomes.
Matušková V; Vysloužilová D; Uher M
Semin Ophthalmol; 2018; 33(5):690-699. PubMed ID: 29252091
[TBL] [Abstract][Full Text] [Related]
13. Central serous chorioretinopathy with and without steroids: A multicenter survey.
Araki T; Ishikawa H; Iwahashi C; Niki M; Mitamura Y; Sugimoto M; Kondo M; Kinoshita T; Nishi T; Ueda T; Kato A; Yasukawa T; Takamura Y; Gomi F
PLoS One; 2019; 14(2):e0213110. PubMed ID: 30818363
[TBL] [Abstract][Full Text] [Related]
14. Clinical experience with eplerenone to treat chronic central serous chorioretinopathy.
Cakir B; Fischer F; Ehlken C; Bühler A; Stahl A; Schlunck G; Böhringer D; Agostini H; Lange C
Graefes Arch Clin Exp Ophthalmol; 2016 Nov; 254(11):2151-2157. PubMed ID: 27145785
[TBL] [Abstract][Full Text] [Related]
15. RISK OF EXUDATIVE AGE-RELATED MACULAR DEGENERATION IN PATIENTS WITH CENTRAL SEROUS CHORIORETINOPATHY: A Nationwide Cohort Study.
Lee JY; Bae K
Retina; 2022 May; 42(5):852-858. PubMed ID: 35067609
[TBL] [Abstract][Full Text] [Related]
16. The Effect of Obstructive Sleep Apnea on Absolute Risk of Central Serous Chorioretinopathy.
Pan CK; Vail D; Bhattacharya J; Cao M; Mruthyunjaya P
Am J Ophthalmol; 2020 Oct; 218():148-155. PubMed ID: 32574769
[TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of neovascular and non-neovascular chronic central serous chorioretinopathy (CSC) diagnosed by swept source optical coherence tomography angiography (SS OCTA).
Sulzbacher F; Schütze C; Burgmüller M; Vécsei-Marlovits PV; Weingessel B
Graefes Arch Clin Exp Ophthalmol; 2019 Aug; 257(8):1581-1590. PubMed ID: 31037488
[TBL] [Abstract][Full Text] [Related]
18. Collaborative retrospective macula society study of photodynamic therapy for chronic central serous chorioretinopathy.
Lim JI; Glassman AR; Aiello LP; Chakravarthy U; Flaxel CJ; Spaide RF;
Ophthalmology; 2014 May; 121(5):1073-8. PubMed ID: 24439758
[TBL] [Abstract][Full Text] [Related]
19. Central serous chorioretinopathy after renal transplantation.
Lee CS; Kang EC; Lee KS; Byeon SH; Koh HJ; Lee SC
Retina; 2011 Oct; 31(9):1896-903. PubMed ID: 21499191
[TBL] [Abstract][Full Text] [Related]
20. Central serous chorioretinopathy associated with topical corticosteroids in a patient with psoriasis.
Ezra N; Taban M; Behroozan D
J Drugs Dermatol; 2011 Aug; 10(8):918-21. PubMed ID: 21818516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
